Catalyst Pharmaceuticals (CPRX) Cash from Operations (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Cash from Operations of 59587000.0 for Q1 2026, up 32.74% on a QoQ basis from 44891000.0 in Q4 2025, and down 0.76% year-over-year from 60043000.0 in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Cash from Operations (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Cash from Operations history runs 17 years deep, the most recent figure standing at 59587000.0 for Q1 2026.
- Quarterly Cash from Operations fell 0.76% year-over-year to 59587000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 208214000.0 (down 22.29% YoY) and the FY2025 annual result came in at 208670000.0, down 12.98% from the prior year.
- Cash from Operations was 59587000.0 for Q1 2026 at Catalyst Pharmaceuticals, up from 44891000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 72871000.0 in Q3 2024 and bottomed at 8478000.0 in Q1 2022.
- A 5-year average of 45159529.41 and a median of 44891000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations soared 164.5% — and 2025, when it sank 55.49%.
- Catalyst Pharmaceuticals' Cash from Operations stood at 40077000.0 in 2022, then jumped by 38.85% to 55648000.0 in 2023, then advanced by 27.37% to 70877000.0 in 2024, then tumbled by 36.66% to 44891000.0 in 2025, then soared by 32.74% to 59587000.0 in 2026.
- Business Quant data shows CPRX's Cash from Operations at 59587000.0 in Q1 2026, 44891000.0 in Q4 2025, and 32438000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 59.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.59 Mn |
| Mar 31, 2026 | 59.59 Mn |
| Dec 31, 2025 | 44.89 Mn |
| Dec 31, 2025 | 44.89 Mn |
| Sep 30, 2025 | 32.44 Mn |
| Sep 30, 2025 | 32.44 Mn |
| Jun 30, 2025 | 71.30 Mn |
| Jun 30, 2025 | 71.30 Mn |
| Mar 31, 2025 | 60.04 Mn |
| Mar 31, 2025 | 60.04 Mn |
| Dec 31, 2024 | 70.88 Mn |
| Dec 31, 2024 | 70.88 Mn |
| Sep 30, 2024 | 72.87 Mn |
| Sep 30, 2024 | 72.87 Mn |
| Jun 30, 2024 | 64.14 Mn |
| Jun 30, 2024 | 64.14 Mn |
| Mar 31, 2024 | 31.93 Mn |
| Mar 31, 2024 | 31.93 Mn |
| Dec 31, 2023 | 55.65 Mn |
| Dec 31, 2023 | 55.65 Mn |